Alpha Tau Medical (NASDAQ:DRTS) Stock Rating Reaffirmed by H

HC Wainwright reaffirmed their buy rating on shares of Alpha Tau Medical (NASDAQ:DRTS – Free Report) in a report issued on Wednesday, Benzinga reports. The firm currently has a $9.00 price objective on the stock. HC Wainwright also issued estimates for Alpha Tau Medical’s FY2024 earnings at ($0.46) EPS, Q1 2025 earnings at ($0.13) EPS, […]

Related Keywords

Israel , United States , Alpha Da , , Usadvisors Wealth Management , Alpha Tau Medical Company Profile , Advisor Group , Alpha Tau Medical Ltd , Satovsky Asset Management , Telemus Capital , Alpha Tau Medical , Free Report , Tau Medical Trading Down , Tau Medical , Get Free Report , Asset Management , Wealth Management , Tau Medical Ltd , Alpha Tau Medical Daily ,